Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on May 22, 2003; DOI 10.1182/blood-2002-11-3444.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-11-3444v1
102/6/1997    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kardos, G.
Right arrow Articles by Niemeyer, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kardos, G.
Right arrow Articles by Niemeyer, C. M.
Related Collections
Right arrow Transplantation
Right arrow Clinical Trials and Observations
Right arrow Immunobiology
Right arrow Red Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 September 2003, Vol. 102, No. 6, pp. 1997-2003

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS

Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7

Gabriela Kardos, Irith Baumann, S. Jane Passmore, Franco Locatelli, Henrik Hasle, Kirk R. Schultz, Jan Stary, Annette Schmitt-Graeff, Alexandra Fischer, Jochen Harbott, Judith M. Chessells, Ian Hann, Susanna Fenu, Angelo Cantú Rajnoldi, Gitte Kerndrup, Elisabeth van Wering, Tim Rogge, Peter Nöllke, and Charlotte M. Niemeyer

From the VU University Medical Center Amsterdam, The Netherlands; Department of Pathology, University of Erlangen, Germany; Childhood Cancer Research Group, Oxford, United Kingdom; IRCCS Policlinico S. Matteo, Pavia, Italy; Skejby Hospital, University of Aarhus, Denmark; Department of Pediatrics, University of British Columbia, Vancouver, Canada; Department of Pediatrics, Second Medical Faculty, Charles University, Prague, Czech Republic; Department of Pediatrics and Pathology, University of Freiburg, Germany; Department of Pediatrics, University of Giessen, Germany; Department of Haematology and Oncology, Great Ormond Street Children's Hospital, London, United Kingdom; Cattedra di Ematologia, University La Sapienza of Roma, Italy; Laboratory Department, Istituti Clinici di Perfezionamento, Milan, Italy; Department of Pathology, University of Odense, Denmark; and the Dutch Children Leukemia Study Group, The Hague, The Netherlands.

Primary myelodysplasia (MDS) without an increased number of blasts is a rare finding in childhood. We performed a retrospective analysis of 67 children with a diagnosis of primary MDS to determine the clinical and hematologic course of the disease. The median age at diagnosis was 8.3 years (range, 0.3-18.1 years). In contrast to refractory anemia in adults, 44% of patients had hemoglobin levels greater than 10 g/100 mL. The median white blood cell count and the absolute neutrophil count were 3.6 x 109/L and 0.9 x 109/L, respectively. Seventy-five percent of patients had thrombocytopenia. Bone marrow was hypocellular in 43% of the patients. Results of cytogenetic analysis showed monosomy 7 in 49%, trisomy 8 in 9%, and other abnormalities in 9% of the patients. The probability of survival 10 years after diagnosis was 0.48 (standard error [SE] = 0.10). Patients with monosomy 7 had significantly higher estimated probabilities of progression to advanced MDS than did patients with other chromosomal anomalies or normal karyotype. Of the 67 children, 41 underwent allogeneic stem cell transplantation (SCT). Patients whose disease did not progress to advanced MDS before SCT had significantly greater probability of survival than patients who experienced progression (0.76 [SE = 0.09] vs 0.36 [SE = 0.16]). SCT improved the outcomes for patients with monosomy 7 and should be offered early in the course of the disease. Recommendations for best treatment options for children with other chromosomal abnormalities or normal karyotype may have to await results of prospective clinical trials.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. Hasle, T. A. Alonzo, A. Auvrignon, C. Behar, M. Chang, U. Creutzig, A. Fischer, E. Forestier, A. Fynn, O. A. Haas, et al.
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study
Blood, June 1, 2007; 109(11): 4641 - 4647.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. Yoshimi, I. Baumann, M. Fuhrer, E. Bergstrasser, U. Gobel, K.-W. Sykora, T. Klingebiel, U. Gross-Wieltsch, M. M van den Heuvel-Eibrink, A. Fischer, et al.
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia
Haematologica, March 1, 2007; 92(3): 397 - 400.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
C.-H. Pui, M. Schrappe, R. C. Ribeiro, and C. M. Niemeyer
Childhood and Adolescent Lymphoid and Myeloid Leukemia
Hematology, January 1, 2004; 2004(1): 118 - 145.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020